Albumedix submits Drug Master Files for its products in Japan Kumar Jeetendra | January 25, 2021 Nottingham, UK – January 25th, 2021 – Life Science Newswire – Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rHA), announced the submission of Drug Master Files (DMFs) to the Pharmaceutical and Medical Device Agency (PMDA) in Japan. Albumedix has submitted DMFs for two of their products in order to further support customers …
SMART Designs Tool to Investigate Bacteria Behind Hospital Infections Kumar Jeetendra | January 26, 2021 Singapore, 26 January 2021 – Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and Nanyang Technological University (NTU) have developed a tool using CRISPRi technology that can help understand and prevent biofilm development, drug resistance, and other physiological behaviours of …
WHO gives new clinical guidance on treating COVID-19 patients Kumar Jeetendra | January 26, 2021 The World Health Organization (WHO) issued fresh clinical advice on Tuesday for treating COVID-19 patients, including those displaying persistent symptoms after recovery, and said it suggested using low-dose coagulants to prevent blood clots. WHO spokeswoman Margaret Harris told a UN briefing in Geneva that a WHO-led group of independent experts, currently in the central Chinese …
Saudi Arabia to get AstraZeneca shots in about seven days from India Kumar Jeetendra | January 26, 2021 The Serum Institute of India (SII) will provide Saudi Arabia with 3 million AstraZeneca COVID-19 vaccine doses priced at $5.25 each in about a week on behalf of the British drugmaker, its chief executive told Reuters on Monday. SII, the world’s biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine …
Rersearch shows quick period of vein rebuilding after aneurysm Kumar Jeetendra | January 26, 2021 Hitting a pothole on the road in only the wrong way might create a bulge on the tire, a weakened spot that will almost certainly result in an eventual flat tire. But what if that tire could immediately begin reknitting its rubber, strengthening the bulge and preventing it from bursting? That’s exactly what blood vessels …
World’s first completely reversible control of the circadian clock Kumar Jeetendra | January 26, 2021 The Nagoya University Institute of Transformative Bio-Molecules (WPI-ITbM) research team of Designated Associate Professor Tsuyoshi Hirota, Postdoctoral Fellow Simon Miller, Professor Kenichiro Itami and grad student Tsuyoshi Oshima (Research Fellowship for Young Scientists, JSPS), in collaboration with the team of Professor Ben Feringa and Postdoctoral Fellow Dušan Kolarski of Groningen University in the Netherlands, have …
UNSW builds up a clay based ink to 3D-print bone parts with living cells Kumar Jeetendra | January 26, 2021 3D printers may one day become a permanent fixture of the operating theatre after UNSW scientists showed they could print bone-like structures comprising living cells. Researchers from UNSW Sydney have developed a ceramic-based ink which may allow surgeons in the long run to 3D-print bone elements complete with living cells which could be used to …
SPT Labtech Announces a Co-Marketing Initiative with Thermo Fisher Scientific to Help Reduce the Cost of NGS Library Prep Kumar Jeetendra | January 27, 2021 Cambridge, UK – January 26 2021 – The cost of library preparation is one of the biggest obstacles to large next-generation sequencing (NGS) studies, slowing down the pace of insights from infectious disease surveillance, cancer research and beyond. At the Festival of Genomics, SPT Labtech announced an initiative with Thermo Fisher Scientific to co-market solutions …
PromoCell GmbH receives EXCiPACT™ certification as manufacturer of pharmaceutical excipients to Good Manufacturing Practice (GMP) standards Kumar Jeetendra | January 27, 2021 Heidelberg, Germany, 28 January 2021 – Life Science Newswire – PromoCell, one of the leading European manufacturers of human cell culture and cell biology products, has announced to have successfully completed a comprehensive EXCiPACT™ audit that certifies the company as a manufacturer of pharmaceutical excipients to Good Manufacturing Practice (GMP) standards. The EXCiPACT™ certification scheme …
‘Next-gen’ COVID-19 immunizations might be expected to handle arising variants, say researchers Kumar Jeetendra | January 27, 2021 The spread of COVID-19 variants is not an immediate problem but it’s time already for next-gen preventives to handle them, say scientists as nations fine-tune their vaccine dissemination programmes and the race to place additional vaccines in the market gathers pace. Work on vaccines will have to continue on parallel tracks — one to undertake …
Study shows why children of obese moms have inclination to create metabolic illnesses Kumar Jeetendra | January 27, 2021 A Brazilian study published in the journal Molecular Human Reproduction helps understand why overweight mothers often have children with a propensity to develop metabolic disease during their lifetime, according to previous research. According to the authors,”transgenerational transmission of metabolic disorders” may be associated with Mfn2 deficiency in the mother’s oocytes (immature eggs). Mfn2 refers to …
Cipla champions its commitment to carbon neutrality with its 30 MW solar plant in Maharashtra Kumar Jeetendra | January 27, 2021 India; January 27, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has set up a 30 MW solar group captive project in Tuljapur, Maharashtra. Spread across 115 acres, the solar project has been commissioned in partnership with AMP Energy India, and is one of the largest solar …
